The latest CNS tumor classification has indicated that CDKN2A/B homozygous deletion represents a poor prognosis in astrocytoma [14], but there are no reports using CDKN2A/B and MRI features to predict survival in LGGs. This evidence concerns the gene CDKN2A and central nervous system neoplasm.